Astellas Inks $1.54 Billion Licensing Deal with Evopoint for ADC Candidate XNW27011 Targeting CLDN18.2

- Agreement grants Astellas exclusive worldwide rights (excluding China's mainland, Hong Kong, Macao and Taiwan region) to develop and commercialize XNW2...

May 30, 2025 | Friday | News
Alvotech and Advanz Pharma Expand Biosimilars Partnership with Three New Candidates in Europe

Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a U...

May 29, 2025 | Thursday | News
Sanofi Completes $600M Acquisition of DR-0201, Expanding Immunology Pipeline with First-in-Class Myeloid Cell Engager

 Sanofi announces the completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc., a private...

May 28, 2025 | Wednesday | News
GlycoEra Secures $130M Series B to Advance First-in-Class IgG4 Protein Degrader Into Clinical Trials

Financing led by Novo Holdings with significant support from world-class group of existing and new investors Proceeds from financing to support developm...

May 28, 2025 | Wednesday | News
Angelini Ventures Joins $39M Series A Extension to Advance Therini Bio’s Alzheimer’s and DME Therapy

Angelini Ventures joins top-tier investor syndicate Investment will fund Phase 1b studies evaluating Therini Bio’s lead candidate, THN391, for ...

May 15, 2025 | Thursday | News
QIAGEN Acquires Genoox for $70M to Expand AI-Powered Genomic Interpretation Portfolio

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insigh...

May 13, 2025 | Tuesday | News
LENZ Therapeutics and Lotus Pharmaceutical Ink $125M Licensing Deal to Commercialize LNZ100 for Presbyopia in Asia

LENZ Therapeutics, Inc.  and Lotus Pharmaceutical Co., Ltd. y announced an exclusive license and commercialization agreement for Lotus to commercial...

May 12, 2025 | Monday | News
Addex Therapeutics and Sinntaxis Partner to Advance Dipraglurant for Brain Injury Recovery

Addex Therapeutics  a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neu...

May 01, 2025 | Thursday | News
Kytopen and Aldevron Partner to Streamline CRISPR T-Cell Engineering with Breakthrough Non-Viral Workflow

Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organ...

May 01, 2025 | Thursday | News
CN Bio and Pharmaron Partner to Advance Organ-on-a-Chip Integration in Drug R&D

CN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, announced the establishment o...

April 25, 2025 | Friday | News
Antengene to Present Promising Clinical Data on ATG-037 and ATG-008 at 2025 ASCO Annual Meeting

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commer...

April 24, 2025 | Thursday | News
APhA Unveils Key Recommendations to Expand Pharmacists’ Services Under Medical Benefit

 The American Pharmacists Association announces the release of Recommendations for Health Plans and Pharmacists to Advance Coverage for Pharmacis...

April 22, 2025 | Tuesday | News
Odylia Therapeutics Marks Rare Disease Day with Focus on Funding & Collaboration

Odylia Therapeutics (Odylia) a nonprofit biotechnology company dedicated to expediting drug development for rare diseases, hosted a Rare Disease Day event ...

April 11, 2025 | Friday | News
Gift of Life Biologics and Cellex Cell Professionals Celebrate Ongoing Success of Collaborative Partnership in Cell and Gene Therapy

Gift of Life Biologics, a leading supplier of high-quality cellular starting materials in the US, and Cellex Cell Professionals, a trusted Contract De...

April 08, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close